Bluffton University. N. Arokkh, MD: "Buy online Pyridium cheap - Discount Pyridium online no RX".
Pepper-spray induced respiratory failure treated with extracorporeal membrane oxygenation generic pyridium 200 mg without a prescription gastritis diet ēóšõąé. The effect of oleoresin capsicum āpepperā spray inhalation on respiratory function order genuine pyridium gastritis diet įåņńčņč. Clinical effects of oleoresin capsicum (pepper spray) on the human cornea and conjunctiva pyridium 200mg low price gastritis pain. Effects of oleoresin capsicum pepper spray on human corneal morphology and sensitivity buy 200mg pyridium amex gastritis diet ēłźņł. Riot control agents: biomedical and health aspects of the use of chemicals in civilian disturbances. Acute pulmonary effects fromO-chlorobenzylidemalonitrile ātear gasā: a unique exposure outcome unmasked by strenuous exercise after a military training event. Tear gasāits toxicology and suggestions for management of its acute effects in man. Medical Issues of Restraint 195 Chapter 7 Medical Issues Relevant to Restraint Nicholas Page 1. Forensic phy- siciansā involvement with these issues involves many of the core attributes needed in the practice of high-quality forensic medicine, includ- ing the need for good history taking from as many involved parties as is prac- tical to clearly establish events, and a precise examination recorded clearly and contemporaneously. Objectivity must be maintained in the light of dif- fering histories, and there is a need to keep abreast of developing restraint techniques that may bring new clinical problems. However, regardless of how careful police officers may be, there is the potential for serious injury requir- ing further medical intervention, and the real possibility of being a witness in a legal process, such as police disciplinary procedures. During restraint, any force used must be proportionate to the threat faced, lawful, and necessary. The restraint process is particularly challenging where the potential detainee has a mental health problem or is intoxicated. In addi- tion, the officer, in retrospect and under close scrutiny, must be able to dem- onstrate that his or her actions were entirely appropriate. It must be recognized From: Clinical Forensic Medicine: A Physicianās Guide, 2nd Edition Edited by: M. As an independent doc- tor, excellent clinical management by the forensic physician throughout the case enables the doctor to act as a high-quality witness if needed. The doctor also has a duty to report any instance where excessive restraint appears to have been used, and such concerns should be communicated to the senior police officer on duty immediately. The forensic physician needs to be aware that equipment may be misused; for example, a long-barreled metal torch could be used as a striking weapon in some circumstances, and, indeed such lights were withdrawn in the United States to prevent this from happening. Although the basic principles of restraint are similar throughout the world, there are many variations both throughout countries and within individual states where there are no national police forces. It is also an evolving subject involv- ing research by organizations, such as the Police Scientific Development Branch in the United Kingdom, as well as the practical outcome of restraint tech- niques when used by officers. Rigid handcuffs, such as Kwik Cuffs, were first trialed in 1993 and have since become standard issue in the United Kingdom and the United States. Although the ratchet mechanism is the same as with the older cuffs, the fixed joint between the cuffs gives several distinct advantages. Holding the fixed joint allows easy application because simple pressure against the wrist enables the single bar to release over the wrist and engage the ratchet. The ratchet can be locked to prevent further tightening but can also only be released with the key, which requires the detainee to cooperate by keeping still. Correctly tightened cuffs should just have enough space for an additional finger between the applied cuff and wrist. The hands are usually cuffed behind the back one above the other, because handcuffing to the front may provide opportunities to resist detention. Even with only one wrist in the cuffs, control by the officer can be gained by essentially using the free cuff and rigid link as a lever to apply local painful pressure to the restrained wrist. Techniques allow a detainee to be brought to the ground in a controlled manner or the other wrist to be put within the cuffs. Medical Issues of Restraint 197 A gentle application, such as may be experienced by the forensic physician in a personal trial, will demonstrate that it is clearly an effective way of gaining control of most individuals. This may not be the case in those who are intoxi- cated, have mental health issues, or are violent. Cuffs should fit firmly but not tightly at the narrowest part of the wrist just distal to the radial and ulna sty- loid processes. Injuries From Handcuffs Injuries from handcuffs either reflect relative movement between the cuff and wrist or are the result of direct pressure from the cuff to the tissues of the wrist. It is important to remember that injuries may be unilateral, especially where there has been resistance to their application. The most common injuries found are erythema, abrasions, and bruis- ing, particularly to the radial and ulna borders of the wrist (2). The erythema is often linear and orientated circumferentially around the wrist following the line of the handcuffs, reflecting direct pressure from the edge of the cuffs. Bruising is commonly seen on the radial and ulna borders, with tender swelling often associated with abrasions or superficial linear lacerations from the edge of the cuff. However, it is not possible to determine whether this move- ment is from the cuff moving over the wrist or the wrist moving within the cuff, because either can produce the same skin abrasions. All of these soft tissue injuries will resolve uneventfully during the course of several days, and only symptomatic treatment with simple analgesia and possibly a cold compress is required. Although rare, it is possible to have wrist fractures from restraint using handcuffs. The styloid processes are the most vulner- able, but scaphoid fractures have been reported (3). Tenderness beyond that expected for minor injuries and especially tenderness in the anatomical snuff- box will need an X-ray assessment as soon as possible. The earliest reports of sensory damage to the nerves of the wrist first appear in the 1920s, with sensory disturbance often restricted to a small patch of hyperesthesia and hyperalgesia on the extensor aspect of the hand between the thumb and index finger metacarpals (4). This area reflects damage to the superficial branch of the radial nerve and subsequent studies confirm that this nerve is most commonly affected by compression between handcuffs and the dorsal radius (5). However, injuries to the median and ulna nerves can also occur, and these may be isolated or in any combination. The superficial branch of the radial nerve may be spared with others being damaged (6). Resultant symptoms are reported as lasting up to 3 years in one case; pain may be severe and prolonged, although the most disturbing symptom to patients is paresthe- 198 Page sia (5). Nerve conduction studies may be used to distinguish between a com- pressive mononeuropathy and a radiculopathy. The majority of cases with sig- nificant nerve damage either involve detainees who are intoxicated or have a clear history of excessive pressure being applied by the officers (5). Intoxica- tion may cause problems through a decreased awareness of local pain, marked uncooperativeness, or poor memory for the restraining episode when a signifi- cant struggle occurred. It is possible to have nerve damage with no skin break- age, reflecting undue pressure.
Ras mutations are common in at least 80% of pancreatic cancers buy pyridium without a prescription gastritis diet 4 rewards, indicating that this genetic alteration is part of the multistep oncogenesis of pancreatic cells buy pyridium with visa gastritis diet šįź. The c-myc cellular expression is associated with cellular proliferation and inversely related to cellular differentiation discount pyridium 200 mg visa gastritis diet alcohol. It has been noted that constitutive expression of c-myc results in the inability of a cell to exit the cell cycle order generic pyridium on line gastritis gluten. In certain cancers, such as colon cancer, no genetic mutation in c-myc has been found. Thus, loss of posttranscriptional regulation is, at least, partially responsible for cellular proliferation. In all cases, the genetic abnormalities of onco- gene expression represent speciļ¬c targets for gene therapy. Some retro- virus contain transforming genes called v-onc, for viral oncogene, in addition to the typically encoded genes such as gag, pol, and env (see Chapter 4). Viral oncogenes are derived from cellular oncogenes with differences arising from genetic alterations such as point mutations, deletion, insertions, and substitutions. Cellular oncogenes are presumed to have been captured by retroviruses in a process termed retroviral transduction. This occurs when a retrovirus inserts into the genome in proximity to a cellular oncogene. A new hybrid viral gene is created and, after transcription, the new v-onc is incorporated into the retroviral particles and introduced into neighboring cells by transfection. Tumor Suppressor Genes Tumor suppressor genes encode for molecules that modify growth of cells through various mechanisms including regulation of the cell cycle. An abnormality in a tumor suppressor gene could result in a loss of functional gene product and susceptibility to malignant transformation. Thus, restoration of tumor suppressor gene function by gene therapy, particularly in a premalignant stage, could result in conversion to a normal cellular phenotype. Possibly, the restoration of tumor suppressor gene function in malignant cells could result in the āreverse transformationā of a malig- nant cells to a nonmalignant cell type. Thus, by the action of p53, malignant cells or premalig- nant cells can be inhibited or killed and phagocytosed. Alternatively, loss of the p53 gene by mutation, deletion, or inhibition of the p53 tumor suppressor molecule has been implicated in tumor progression. Inactivation of p53 can occur by various mechanisms including genetic mutation, chromosomal deletion, binding to viral oncoproteins, binding to cellular oncoproteins such as mdm2, or alteration of the subcellular location of the protein. It has been estimated that p53 is altered, in some form, in half of all human malignancies. For all of these reasons, individuals with p53 abnormalities represent potential candidates for gene therapy. Mismatched base errors, if not corrected, are replicated in repeated cell divisions and promote genomic instability. If a gene is dysfunctional through a genetic alteration, compensation can occur by numerous mechanisms. For a loss of function scenario, such as for a tumor sup- pressor gene, compensation would be provided by the transfer of a dominant normal gene or by directly correcting the gene defect. If a gene incurs a gain in function, such as for an oncogene or growth factor, then approaches at gene deletion or regulation of gene expression could be employed. Augmentation of Tumor Suppressor Genes Tumor suppressor genes are a genetically distinct class of genes involved in sup- pressing abnormal growth. Study of ācancer familiesā predisposed to distinct cancer syndromes has led to the identiļ¬cation of mutated tumor suppressor genes transmitted through the germline. Individuals from these families are more susceptible to cancer because they carry only one normal allele of the gene. The most targeted tumor suppressor gene for gene therapy has been p53 (see Table 10. This is because p53 is the most com- monly mutated tumor suppressor gene in human cancer. The transfer of p53 gene to tumor cells in vitro results in a transduction that suppresses growth, decreases colony formation, reduces tumorgenicity of the cells, and induces apopotosis. In addition, normal cells have been shown to remain viable after transfection and over- expression of the p53 gene. Clinical studies with the p53 gene have begun, and many obstacles to successful therapy need to be overcome. Numerous gene therapy delivery systems will be needed to match the clinical application for optimal therapy. Differing delivery systems will be needed for local intratumor delivery of tumors versus systemic delivery to blood-borne or metastatic disease. Retrovirus For retroviral vectors, a signiļ¬cant advantage is the preferential inte- gration of the p53 transgene into rapidly dividing tumor cells as compared to normal cells. However, this integration is genomic and thus represents a permanent modi- ļ¬cation of the cells. In addition, one cannot discount the possibility of insertional mutagenesis of normal cells with the p53 transgene. Thus, improvements in current generation retrovirus vectors are needed for effective in vitro or ex vivo therapy with p53. Adenovirus and Adenoassociated Virus For adenovirusābased gene delivery systems, adenovirus, adenoassociated virus, herpes, and vaccinia virus have been explored for gene therapy (see Chapter 4). For gene therapy using the p53 trans- gene, adenovirus and vaccinia virus have been used. The signiļ¬cant advantages of theses vectors include (1) the transduction of dividing or quiescent cells, (2) wide tissue tropism, and (3) the ability to generate clinical-grade material at high concentrations. The adenovirus remains extrachromosomal, and thus transient transgene occurs with replication-defective recombinant adenoviruses. Short-term expression of p53 may be advantageous for treatment of neoplasia if the induction of growth inhibition, reduction in colony formation, or reduction in tumorgenicity is permanent in targeted cancer cells. Certainly, if apoptosis is induced by transient p53 expression, individual tumor cells would be clonally deleted. A difļ¬cult com- plication of therapy would be the observation of these biological processes in normal cells. However, replication-deļ¬cient adenovirus has been used in clinical studies without signiļ¬cant adverse side effects to normal cells. Another signiļ¬cant issue in the use of adenovirus is the hostās immune response to the vector. Both neutralizing antibody and cytotoxic T-cell cells have been shown to inhibit the efļ¬- cacy of adenovirus-based gene therapy. Most recent generations of adenovirus vectors have speciļ¬cally addressed this issue and signiļ¬cantly reduced the immuno- genicity of the vector construct. Thus, it is likely that delivery of the p53 transgene by an adenovirus vector will provide the initial demonstration of effective gene therapy for cancer.
Buy pyridium 200 mg with amex. How to Treat a Stomach Flu or Virus | Stomach Problems.
Lochnera rosea (Madagascar Periwinkle). Pyridium.
- Are there safety concerns?
- Dosing considerations for Madagascar Periwinkle.
- How does Madagascar Periwinkle work?
- Diabetes, cancer, fluid retention, cough, lung congestion, sore throat, eye irritation, skin infections, and other conditions.
- Are there any interactions with medications?
- What is Madagascar Periwinkle?
However buy genuine pyridium on line gastritis diet ’ķäåźń, has implementation of the bundles themselves led to improved outcomes order 200 mg pyridium overnight delivery gastritis or gallbladder, or is it just that the quality of care in general has im- proved because of improved sepsis diagnosis and increased attentiveness to management goals? The bundle approach has some limitations purchase pyridium 200 mg otc gastritis diet ģóėüņčźč, which should be remembered when interpreting the associated data discount pyridium 200mg without prescription gastritis diet žņžį. For example, low-dose steroids, tight glucose control and drotrecogin alpha (ac- tivated) are all therapies for which data are conĆicting or debated, yet they are included in the management bundle. In the resuscitation bundle, Ćuids and vasopressors are included, but does it make a difference which Ćuid or vasopressor is used? High-quality, randomised controlled trial data in support of an intervention are relatively rare in intensive care medi- cine as a whole and in sepsis in particular . As long as evidence for some bundle components remains disputable, how can the impact of the bundles as a whole be assessed and interpreted? Moreover, institution of sepsis bundles with unproven components may lead physicians to provide inappropriate or even harmful care . Second, as new study results are published, when and how should the bundles be adapted? Third, there is con- siderable evidence that early diagnosis and initiation of appropriate therapy is crucial in patients with sepsis ā e. Rather than encouraging completion of a bundle within 6 or 24 h, it may be better to en- courage completion of each component āas soon as possibleā (and, of course, to record it). Our recent study suggested that outcomes could have been improved if the sepsis manage- ment bundle had been completed within 12 h rather than the recommended 24-h . It has taught us important lessons about guideline devel- opment and highlighted the lack of good-quality evidence in intensive care medicine. The development of sepsis bundles has helped promote discussion of the optimal approach to sepsis management and has introduced some degree of uniformity to the process of treat- ing patients with severe sepsis. It has encouraged a more standardised approach to patient management at a global level. Where the management of patients with sepsis is already optimal and follows best practice, starting to use bundles of care is unlikely to make any difference to mortality rates and may even represent a step backwards by restricting the freedom of trained intensivists to use their skills and expertise to adapt management to the individual patient. Zambon M, Ceola M, Almeida-de-Castro R et al (2008) Implementation of the Surviving Sepsis Campaign guidelines for severe sepsis and septic shock: we could go faster. Crit Care Med 34:1025ā 1032 18 What Have We Learned from the Surviving Sepsis Campaign? Girardis M, Rinaldi L, Donno L et al (2009) Effects on management and outcome of severe sepsis and septic shock patients admitted to the intensive care unit after implementation of a sepsis program: a pilot study. Rivers E, Nguyen B, Havstad S et al (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. Severe sepsis is deĀæned as sepsis plus sepsis-induced organ dysfunction or tissue hypoperfusion [2, 3]. The term source control was Āærst used in the early twentieth century but regained attention over the past 10 years when a panel of ex- perts was asked to provide guidelines for treating severe sepsis and septic shock during the Surviving Sepsis Campaign project. A bundle is a simple principle of care resulting from evidence-based practice guidelines that, when implemented as a group, have a signiĀæcant effect on outcomes beyond implementing the individual elements alone. Each hospital can elaborate a sepsis protocol, but it must meet the standards created by the bundle . However, sepsis often requires time to manifest and may rapidly develop with fatal consequences. Any infection starts with the invasion of host tissues by microorganism, which creates human immune system res- ponse, which activates an inĆammatory process to challenge the invasion. Understanding this pathophysiological cascade permits clarifying the principles of source-control: drainage, debridement and deĀænitive measures to control the effects of injury and restore the previ- ous correct function . To achieve this identiĀæca- tion, the clinician should always consider clinical and laboratory signs of sepsis. Further- more, an early identiĀæcation (according to the guidelines in the Āærst 6 h) improves out- comes, reducing both mortality rates and costs [4, 5, 9, 10]. Once an infection site has been identiĀæed, the clinician should consider which procedure is more effective and safest for the patient: supported source-control measures are draining an abscess or local focus of in- fection, debriding infected necrotic tissue, removing a potentially infected device or deĀæni- tively controlling a source of ongoing microbial contamination (Table 19. To avoid more invasive procedures, percutaneous and endoscopic treatment is preferred to surgery when possible . Such infectious foci should be controlled as soon as possible following successful initial resuscitation and antibiotic treatment [12ā14]. The only exception to these criteria is peripancreatic necrosis, as a randomised, controlled trial comparing early vs. Antibiotic treatment must be started rapidly, but any kind of microbiologi- cal identiĀæcation must be performed prior to beginning antibiotic treatment . Promptly removing intravascular access devices that are potentially the source of severe sepsis or septic shock, after establishing another vascular access, is an important source-control measure . Drainage may occur spontaneously or can be obtained with surgi- cal intervention or percutaneously. When evaluating the drainage method, the physician should choose the one that permits full drainage of the septic collection with the least 19 Source Control 229 Table 19. Percutaneous drainage Absolute indications Extended indications Non loculated Ćuid collections Multi loculated and multiple abscesses No communication between abscess and viscus Abscesses with Āæstula No fungal aetiology Pancreatic Ćuid collections Abscesses secondary to appendicitis or acute diverticulitis Retroperitoneal abscesses Pelvic abscesses physical trauma to the patient. Laparoscopic drainage of abdominal abscesses showed no signiĀæcant advantage over open surgery or percutane- ous technique . A plastic drain is normally left in to support the communication cre- ated by any of these techniques. There are four main methods of debridement: autolytic, mechanical, enzymatic and surgical. Surgical debridement remains the standard of care and consists of removal of devitalised tissue by a physician using a scalpel, scissors or other sharp instrument [4, 11]. Autolytic and enzymatic debridements are enzymatic processes that liq- uefy nonviable tissues . Physicians help autolysis with moist wound dressings (mainly hydrocolloids and hydrogels), whereas a direct enzymatic action is obtained with topical ointments, such as collagenase, promoting debridement. Mechanical debridement generally occurs when patients use dressings that adhere to wounds, which are usually wet-to-dry dressings . With any of these methods, debridement is of paramount importance, as it permits the development of a clear demarcation between necrotic and adjacent vital tissue. Timing for debridement differs in many conditions characterised by different risks and different evolution. In necrotising fasciitis, the spread of tissue necrosis is quick, so it needs early and aggressive debridement to attain a good outcome . In other types of infections, such as retroperitoneal infections, the high risk of complications suggests de- laying the debridement to guarantee a safer procedure .
Homepage with unknown place of publication Publisher for Homepages (required) General Rules for Publisher ā¢ A publisher is defned as the individual or organization issuing the homepage ā¢ Record the name of the publisher as it appears on the homepage or opening screens pyridium 200 mg visa gastritis diet äšīģ, using whatever capitalization and punctuation is found there ā¢ Abbreviate well-known publisher names with caution to avoid confusion order cheap pyridium line chronic gastritis gallbladder. When a homepage does not clearly state the name of the publisher: ā¢ Look at the top order 200mg pyridium gastritis atrophic symptoms, bottom order pyridium mastercard chronic gastritis meaning, or sidebar of the frst screen or the bottom of the last screen of the homepage ā¢ Look for the name afer a copyright statement, e. Publisher information is required in a citation; distributor information may be included as a note. If you abbreviate a word in one reference in a list of references, abbreviate the same word in all references. Lisbon: Imprensa Medica; ā¢ Romanize names in Cyrillic, Greek, Arabic, Hebrew, Korean Sofa (Bulgaria): Sofa Medizina i Fizkultura; ā¢ Romanize names or translate names in character-based languages (Chinese, Japanese). Place all translated publisher names in square brackets unless the translation is given on the Web site. Tokyo: Medikaru Rebyusha; Beijing (China): [Chinese Academy of Social Sciences, Population Research Institute]; Taiyuan (China): Shanxi ke xue ji she chu ban she; [Note that the concept of capitalization does not exist in Chinese. Terefore in transliterating Chinese publisher names only the frst word and proper nouns are capitalized. Tis rule ignores some conventions used in non-English languages to simplify rules for English-language publications. Aarhus (Denmark): Aarhus-Universitetsforlag [Aarhus University Press]; ā¢ As an option, you may translate all publisher names not in English. Place all translated publisher names in square brackets unless the translation is given on the Web site. Jointly published by the University of Alabama School of Law and the Alabama Department of Mental Health & Mental Retardation. For publications with joint or co-publishers, use the name given frst as the publisher and include the name of the other(s) as a note if desired. Jointly published by the University of Alabama School of Law and the Alabama Department of Mental Health & Mental Retardation. Homepage with unknown publisher Date of Publication for Homepages (required) General Rules for Date of Publication ā¢ Use the date the homepage was frst placed on the Internet ā¢ Always give the year ā¢ Convert roman numerals to arabic numbers. Some homepages clearly state the date that the site was placed on the Internet, using such phrases as "frst published", "created", and "began". When they do not: ā¢ Look for the date at the top, bottom, or sidebar of the frst screen or the bottom of the homepage Box 45 continues on next page... For example: copyright 2006 by the American Chemical Society, Ā© 2006 American Medical Association, c2006 Medical College of Wisconsin, c2000-2007 National Rural Health Association. A copyright date is identifed by the symbol Ā©, the letter "c", or the word copyright preceding the date. Tis convention alerts a user that the information in the publication is older than the date of publication implies. If no date of publication can be found, but the homepage contains a date of copyright, use the date of copyright preceded by the letter "c"; for example c2005. Examples: NursingWorld: Ofcial Web site of the American Nurses Association [Internet]. Te date of publication may follow the author names (or type of medium if there is no author) in the list of references when the name-year system of in-text references is used. Washington: Georgetown University, Department of Physiology and Biophysics; c2006 [cited 2007 Mar 23]. Washington: Georgetown University, Department of Physiology and Biophysics; [cited 2007 Mar 23]. Homepage with no date of publication or copyright Date of Update/Revision for Homepages (required) General Rules for Date of Update/Revision ā¢ Homepages are frequently updated or revised afer publication dates or copyright dates ā¢ Begin update/revision information with a lef square bracket ā¢ Use whatever word for update or revision is provided, such as updated, modifed ā¢ Always give the year of update/revision ā¢ Convert roman numerals to arabic numbers. Look for the date accompanied by such words as updated, modifed, revised, reviewed: ā¢ At the top, bottom, or sidebar of the frst screen or the bottom of the last screen of the homepage ā¢ In the source code for the homepage if it is displayed by the Web browser Box 54. Homepage with a date of update and a date of revision Date of Citation for Homepages (required) General Rules for Date of Citation ā¢ Always include the date the homepage was seen on the Internet ā¢ Include the year month and day in that order, such as 2006 May 5 ā¢ Use English names for months and abbreviate them using the frst three letters, such as Jan 1804 Citing Medicine ā¢ If a date of update/revision is given, place the date of citation afer it and follow both dates with a right square bracket ā¢ If no date of update/revision is given, place citation date information in square brackets ā¢ End date information with a period placed outside the closing bracket Specific Rules for Date of Citation ā¢ Both a date of update/revision and a date of citation Box 57. Homepage published with parallel text in two or more languages Notes for Homepages (optional) General Rules for Notes ā¢ Notes is a collective term for any useful information given afer the citation itself ā¢ Complete sentences are not required ā¢ Be brief Specific Rules for Notes ā¢ System requirements ā¢ Web master name ā¢ Other types of material to include in notes Box 62. System requirements describe the particular sofware and hardware needed to view the Web site. Some examples of notes are: ā¢ Information not provided for in the citation rules Complementary/Integrative Medicine [Internet]. Sponsored by the Robert Wood Johnson Foundation, National Governors Association, and the Association of State and Territorial Health Ofcials. Virtual Pediatric Hospitalā¢: a digital library of pediatric information [Internet]. Washington: Georgetown University, Department of Physiology and Biophysics; c2006 [cited 2007 Mar 23]. Virtual Pediatric Hospitalā¢: a digital library of pediatric information [Internet]. Glasgow (Scotland): University of Glasgow, Institute of Biomedical and Life Sciences, Division of Molecular Genetics; [updated 2006 Nov; cited 2007 Feb 21]. London: University of London, Queen Mary, Department of Chemistry; [updated 2006 Jul 24; cited 2007 Feb 22]. Department of Health and Human Services, Ofce of the Assistant Secretary for Preparedness and Response, Tactical Programs Division, Ofce of Emergency Management. Homepage with title having a subtitle NursingWorld: Ofcial Web site of the American Nurses Association [Internet]. Washington: Ornithological Council; c1999-2006 [updated 2006 Dec 8; cited 2007 Feb 20]. Philadelphia: University of Pennsylvania, Abramson Cancer Center; c1994-2007 [cited 2007 Feb 20]. Homepage in a language other than English Societe Francaise de Mycologie Medicale [Internet]. Societe Francaise de Mycologie Medicale [French Society of Medical Mycology] [Internet]. Homepage published with parallel text in two or more languages Health Canada = Sante Canada [Internet]. Homepage published with optional content type Frankenstein: Penetrating the Secrets of Nature [exhibit on the Internet]. Philadelphia: University of Pennsylvania, Abramson Cancer Center; c1994-2007 [cited 2007 Feb 20]. Homepage with place of publication inferred National Library for Health [Internet]. Virtual Pediatric Hospitalā¢: a digital library of pediatric information [Internet]. Philadelphia: University of Pennsylvania, Abramson Cancer Center; c1994-2007 [cited 2007 Feb 20]. National Library of Medicine, Division of Specialized Information Services; 2006 - [updated 2011 Feb 1; cited 2015 Jan 26]. Web Sites 1815 National Library of Medicine; 2012 Jun 18 [updated 2013 Jan 3; cited 2015 Apr 28]. National Library of Medicine; [1998 Oct] - [updated 2015 May 6; cited 2015 May 6].